Inventor
JASON BRYANT CROSS
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
C07BGeneral methods of organic chemistry8%
PatentTitleYear
12,559,497Imidazopiperazine inhibitors of transcription activating proteins202612,540,139Imidazopiperazine inhibitors of transcription activating proteins202612,186,324Imidazopiperazine inhibitors of transcription activating proteins202511,434,233Heterocyclic inhibitors of ATR kinase2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to UNIV TEXAS (4)· patent assignee history
2022Patents assigned to CHEMPARTNER CORP (1)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 4 | 2022–2026 |
| CHEMPARTNER CORP | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2026 |